Richard Daniell, Executive VP, European Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 12,398 shares at $12.24 ($152K) on 2020-02-10, disclosed to the SEC on 2020-02-11.
Open-market sale of $152k TEVA by Executive VP, European Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.24 | 6,199 | $76K | 50.0% |
| 2 | $12.24 | 6,199 | $76K | 50.0% |
| Total | $12.24 avg | 12,398 | $152K | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $6.0M | — | Filing → |
| TEVA | SELL | 2026-03-05 | $8.3M | — | Filing → |
| TEVA | SELL | 2025-12-11 | $6.6M | — | Filing → |